concord Biotech LTDPicture this: Concord Biotech Ltd, a stock showing promising signs of strength. The volume is buzzing, and it's near a resistance level. It needs to spend some time there before I initiate a buy entry.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
29.45INR
3.08 BINR
10.17 BINR
22.53 M
About CONCORD BIOTECH LTD
Sector
Headquarters
Ahmedabad
Website
Founded
2000
ISIN
INE338H01029
FIGI
BBG01HRWT6H8
Concord Biotech Ltd. operates as a research and development based biotechnology company. It manufactures active pharmaceutical ingredients through the process of fermentation, semi-synthetic and synthetic processes. The firm''s products include APIs in the immunosuppressant, antibiotic, oncology, antifungal and hypolipemic segments and enzymes. The company was founded in 2000 and is headquartered in Ahmedabad, India.
Swing Trade In Concord NSE in 1Day TFSwing Trade In Concord NSE in 1Day TF.
Technical Analysis
The stock has reached an all-time high, surpassing its recent resistance level. Additionally, there are two levels of contraction observed in its performance.
1st Contraction is around 13.71%
2nd Contraction is around 06.10%
Target 10%
SL
Concord bio may test 1450Good volume
Maybtest new high
Target 1450
Stop 1350
Posted good sept quarter numbers
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CONCORDBIO is 1395.80 INR — it has decreased by 3.12% in the past 24 hours. Watch CONCORD BIOTECH LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange CONCORD BIOTECH LTD stocks are traded under the ticker CONCORDBIO.
CONCORDBIO stock has fallen by 6.45% compared to the previous week, the month change is a 15.40% fall, over the last year CONCORD BIOTECH LTD has showed a 55.08% increase.
CONCORDBIO reached its all-time high on Apr 30, 2024 with the price of 1725.00 INR, and its all-time low was 900.05 INR and was reached on Aug 18, 2023. View more price dynamics on CONCORDBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CONCORDBIO stock is 6.33% volatile and has beta coefficient of 0.32. Track CONCORD BIOTECH LTD stock price on the chart and check out the list of the most volatile stocks — is CONCORD BIOTECH LTD there?
Yes, you can track CONCORD BIOTECH LTD financials in yearly and quarterly reports right on TradingView.
CONCORD BIOTECH LTD is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
CONCORDBIO net income for the last quarter is 950.16 M INR, while the quarter before that showed 775.73 M INR of net income which accounts for 22.49% change. Track more CONCORD BIOTECH LTD financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONCORD BIOTECH LTD EBITDA is 4.32 B INR, and current EBITDA margin is 42.44%. See more stats in CONCORD BIOTECH LTD financial statements.
Like other stocks, CONCORDBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONCORD BIOTECH LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONCORD BIOTECH LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONCORD BIOTECH LTD stock shows the strong buy signal. See more of CONCORD BIOTECH LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.